PTC TherapeuticsPTCT
那斯達克 · USD
52.13
+0.02
(+0.04%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
PTC TherapeuticsPTCT
52.13
+0.02
(+0.04%)
財務數據
損益表
- 1.67
- 2.20
- 2.14
- 1.97
- 3.07
- 2.10
- 1.87
- 1.97
- 2.13
- 11.76
- -22.90
- 31.64
- -2.98
- -8.06
- 56.20
- -31.57
- -11.14
- 5.40
- 8.33
- 451.71
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 1,176,096 | 213,172 | 196,786 | 186,704 | 210,118 | 307,056 | 196,576 | 213,808 | 220,382 | 167,412 |
營業成本 | 16,660 | 19,590 | 13,884 | 18,392 | 66,270 | 106,292 | 68,142 | 60,128 | 53,559 | 46,657 |
營業毛利 | 1,159,436 | 193,582 | 182,902 | 168,312 | 143,848 | 200,764 | 128,434 | 153,680 | 166,823 | 120,755 |
營業費用 | 189,211 | 355,971 | 237,412 | 208,530 | - | 194,944 | 246,598 | 363,223 | 284,438 | 321,096 |
研發費用 | 108,973 | 124,770 | 161,412 | 132,169 | 116,129 | 121,353 | 164,212 | 185,874 | 195,124 | 188,694 |
推銷及管理費用 | 80,161 | 74,508 | 74,156 | 74,600 | 73,172 | 73,591 | 82,386 | -40,451 | 89,314 | 99,018 |
非經常性項目費用 | 77 | 156,693 | 1,844 | 1,761 | - | - | - | 217,800 | - | 33,384 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 970,225 | -162,389 | -54,510 | -40,218 | -45,453 | 5,820 | -118,164 | -209,543 | -117,615 | -200,341 |
其他收入及費用 | -6,305 | 108,750 | -1,872 | -2,025 | 1,591 | -118,596 | -20,266 | 1,478 | 9,956 | 35,148 |
利息費用 | 34,092 | 41,060 | 41,609 | 43,490 | 40,834 | 44,275 | 28,160 | 29,414 | 27,331 | 24,500 |
稅前純益 | 929,828 | -94,699 | -97,991 | -85,733 | -84,696 | -157,051 | -166,590 | -237,479 | -134,990 | -189,693 |
所得稅 | 63,266 | -28,813 | 8,663 | 13,446 | 6,880 | -1,259 | -33,620 | -38,596 | 3,969 | -18,804 |
稅後純益 | 866,562 | -65,886 | -106,654 | -99,179 | -91,576 | -155,792 | -132,970 | -198,883 | -138,959 | -170,889 |
基本每股稅後盈餘(元) | 11.09 | -0.85 | -1.39 | -1.29 | -1.20 | - | -1.76 | -2.66 | -1.88 | -2.35 |
稀釋每股稅後盈餘(元) | 10.04 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.67 | -1.88 | -2.36 |
基本平均股數(千股) | 78115.00 | 77201.00 | 76925.00 | 76725.00 | 76496.00 | - | 75377.00 | 74730.00 | 73729.00 | 72656.00 |
稀釋平均股數(千股) | 86385.00 | 77201.00 | 76925.00 | 76725.00 | 76496.00 | - | 75377.00 | 74730.00 | 73729.00 | 72656.00 |
還原基本每股稅後盈餘(元) | 11.09 | -0.85 | -1.39 | -1.29 | -1.20 | - | -1.76 | -2.66 | -1.88 | -2.35 |
還原稀釋每股稅後盈餘(元) | 10.04 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.67 | -1.88 | -2.36 |
還原基本平均股數(千股) | 78,115 | 77,201 | 76,925 | 76,725 | 76,496 | - | 75,377 | 74,730 | 73,729 | 72,656 |
還原稀釋平均股數(千股) | 86,385 | 77,201 | 76,925 | 76,725 | 76,496 | - | 75,377 | 74,730 | 73,729 | 72,656 |
EBITDA(千元) | 969,127 | -49,150 | -52,550 | -38,226 | 8,132 | -33,883 | -75,803 | -156,500 | -64,481 | -125,822 |